ALIM - Alimera Sciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
25.56M
Enterprise Value 3
84.18M
Trailing P/E
1.19
Forward P/E 1
-12.00
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
0.51
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
1.67
Enterprise Value/EBITDA 6
-22.87

Trading Information

Stock Price History

Beta (3Y Monthly) 1.45
52-Week Change 3-62.59%
S&P500 52-Week Change 38.78%
52 Week High 31.2100
52 Week Low 30.3200
50-Day Moving Average 30.4282
200-Day Moving Average 30.7308

Share Statistics

Avg Vol (3 month) 3319.72k
Avg Vol (10 day) 3206.19k
Shares Outstanding 571.01M
Float 38M
% Held by Insiders 11.21%
% Held by Institutions 170.89%
Shares Short (Sep 30, 2019) 4313.69k
Short Ratio (Sep 30, 2019) 40.72
Short % of Float (Sep 30, 2019) 40.61%
Short % of Shares Outstanding (Sep 30, 2019) 40.44%
Shares Short (prior month Aug 30, 2019) 4181.81k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 51.28%
Operating Margin (ttm)-12.57%

Management Effectiveness

Return on Assets (ttm)-7.53%
Return on Equity (ttm)2,783.51%

Income Statement

Revenue (ttm)50.37M
Revenue Per Share (ttm)0.71
Quarterly Revenue Growth (yoy)1.30%
Gross Profit (ttm)42.29M
EBITDA -3.68M
Net Income Avi to Common (ttm)21.34M
Diluted EPS (ttm)0.3030
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)12.16M
Total Cash Per Share (mrq)0.17
Total Debt (mrq)40.2M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.67
Book Value Per Share (mrq)-0.48

Cash Flow Statement

Operating Cash Flow (ttm)-3.83M
Levered Free Cash Flow (ttm)1.09M